CJC-1295 research guide

CJC-1295 in Hongtu — GHRH Analog Research Guide

CJC-1295 research guide for Hongtu. Covers DAC vs no-DAC forms, half-life differences, purity testing, and how to source quality CJC-1295 for research.

Skip to Sourcing Guide Order CJC-1295 →

Hongtu Guide to CJC-1295 Research

For anyone in Hongtu looking to source CJC-1295, the foundational reality is that this compound is available only through an online research supply market. What this means for Hongtu researchers is that physical proximity is irrelevant compared to your ability to verify analytical documentation — and those verification methods are available to every researcher. Separating properly characterised CJC-1295 from the rest of the market comes down to three things: an HPLC chromatogram confirming ≥98% purity, mass spec data establishing the correct molecular weight, and a batch-specific endotoxin panel. The sections below cover what Hongtu researchers need to know about finding, evaluating, and storing CJC-1295 for research purposes.

CJC-1295: What the Research Shows

The selectivity profile of different GHS compounds is a critical research consideration. GHRP-6 and GHRP-2 produce GH release alongside cortisol and prolactin elevation — a confounding factor in research designs where these hormones are outcome variables. Ipamorelin was specifically developed for greater GH-release selectivity with minimal cortisol and prolactin elevation, making it more suitable for research designs where GH-specific effects need to be isolated. Hexarelin has the strongest GH-releasing potency in the GHRP class but also the most significant cortisol and prolactin effects. For Hongtu researchers designing GH-axis studies, compound selection based on this selectivity profile should precede protocol finalization.

CJC-1295 Purchasing Guide

The most consistent path to quality CJC-1295 is community research first — peptide forums maintain informal vendor reputation databases that are more trustworthy than marketing materials. When reviewing a CJC-1295 COA, verify: the batch number corresponds to your vial, HPLC purity is ≥98%, mass spec establishes identity, and endotoxin levels are below the threshold for research use. The combination of community consensus and independent COA review is the gold standard for CJC-1295 sourcing — community feedback surfaces recurring issues no single purchase reveals, and vice versa. For Hongtu researchers making a first CJC-1295 purchase: apply these quality criteria before ordering, start with a modest quantity, and confirm the COA batch number matches your received product before use.

Order CJC-1295 — ships to Hongtu
COA-verified · International tracking · Research grade
Order Now →

CJC-1295 Research Safety Guide

Research compound status for CJC-1295 means safety data comes from animal studies, in-vitro work, and limited human observations — rather than the large-scale clinical data that informs approved drug safety. Proper handling of CJC-1295 requires careful sterile procedure — swabbed septum with alcohol prep pad, new needle for each draw, clean preparation area — and cold chain maintenance from receipt through use. Bacterial endotoxin contamination is the greatest safety hazard specific to research peptides — verify endotoxin testing is documented in your batch COA before any injectable research application. For any individual considering CJC-1295 outside a formal research context: consult a qualified physician — this compound is not a licensed human medication and its risk profile is not equivalent to approved medications.

Frequently Asked Questions

What purity is required for CJC-1295 research?

CJC-1295 should be ≥98% pure by HPLC. The larger molecular weight of CJC-1295 with DAC (approximately 3647 Da) makes mass spectrometry confirmation particularly important, as impurities may not be obvious on HPLC alone.

What is CJC-1295?

CJC-1295 is a synthetic GHRH (Growth Hormone Releasing Hormone) analogue. The version with DAC (Drug Affinity Complex) has an extended half-life of approximately 6-8 days due to albumin binding. Without DAC, CJC-1295 has a much shorter half-life similar to native GHRH. Both versions stimulate pulsatile GH release via the GHRH receptor.

What is the difference between CJC-1295 with DAC and without DAC?

CJC-1295 with DAC uses a lysine-maleimide conjugate to bind covalently to albumin in the bloodstream, extending half-life to ~6-8 days and creating sustained GH elevation. CJC-1295 without DAC (also called Mod GRF 1-29) has a half-life of ~30 minutes and produces acute GH pulses. They produce different GH secretion patterns and have different applications in research.

Order CJC-1295 today
COA-verified · International shipping available
Order Now →